CP Reports
Current Agreements
CP Knowledge Centre
CP Consulting

New report

Comprehensive understanding and unprecedented access to the autoimmune partnering deals and agreements entered into by the worlds leading life science companies. More

 

Featured partnering deals

BMS and Bavarian Nordic in Prostvac licensing pact

March 5, 2015 : big pharma, Bristol-Myers Squibb, partnering

Bavarian Nordic and Bristol-Myers Squibb announced an exclusive option to license and commercialize PROSTVAC more »

Intuitive Surgical wins $430m surgical robotic systems contract

March 5, 2015 : medical device, partnering

Intuitive Surgical has been awarded a maximum $430 million fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract for surgical robotic systems more »

 More partnering deals | all deals at Deal Monitor


Featured M&A deals

Mallinckrodt acquires Ikaria for $2.3bn

March 5, 2015 : M&A

Mallinckrodt will acquire Ikaria from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion more »

Baxter acquires Suppremol for $225 million

March 5, 2015 : Baxter, big pharma, M&A

Baxter has acquired SuppreMol for EUR 200 million (approximately $225M USD) before working capital and other adjustments more »

 More M&A deals | all deals at Deal Monitor

Featured financing deals

Tricida gains series B for $30 million

March 5, 2015 : financings

Tricida announced the closing of a $30M Series B financing more »

Serenus Biotherapeutics lands $43m investment

March 4, 2015 : financing

Serenus Biotherapeutics secured investment of up to $43 million from Malin Corporation more »

 More financing deals | all deals at Deal Monitor

Latest Dealtalk

More merger talks for Claris Lifesciences: Pfizer, Amneal, Novartis…

February 18, 2015 : big pharma, dealtalk, M&A, Novartis, Pfizer

India-based CLARIS Lifesciences Ltd., which operates a generic sterile injectables business, has become the belle of the ball as multi-national companies such as Pfizer Inc., Amneal, Novartis AG and Indian companies such as Lupin and Cipla, are lining up to play the more »

Novartis eyes for more pharma deals in Israel

February 17, 2015 : big pharma, dealtalk, Novartis, pharma deals

Novartis , the world’s biggest pharmaceutical (big pharma) company, recently increased its interest in Israel to sign pharma deals. For a long time, the company was active in marketing and clinical trials in Israel, and now it is involved in investment as well. more »

 More dealtalk

Resource quicklinks

NEW Top life science companies deals revealed using our deal making tools.

Company profiles:
Top pharmaceutical companies |
Top biotech companies |
Top pharma company directory

Scorecards: Partnering | M&A |
Financing | Completed IPOs

Featured reports

Discovery Stage Partnering Terms and Agreements

Publication date: March 2015

Preclinical Stage Partnering Terms and Agreements

Publication date: March 2015

Clinical Stage Partnering Terms and Agreements

Publication date: March 2015

Licensing Terms and Agreements

Publication date: February 2015

Diagnostics Partnering Terms and Agreements

Publication date: February 2015

Drug Delivery Partnering Terms and Agreements

Publication date: February 2015

Co-promotion & Co-marketing Partnering Terms and Agreements

Publication date: February 2015

Vaccine Partnering Terms and Agreements

Publication date: February 2015

Distribution Partnering Terms and Agreements

Publication date: February 2015

Oncology Partnering Terms and Agreements

Publication date: January 2015

Antibody Partnering Terms and Agreements

Publication date: January 2015

Infectious Vaccines Partnering Terms and Agreements

Publication date: January 2015

Antibiotics Partnering Terms and Agreements

Publication date: January 2015

View all reports

Print Friendly
cpbannerad300x150new1gif
RSS FeedLinked InTwitter

Latest Tweets

cabannerad300x150new4gif
stem-celljpg
biovisionpng